TrialMedical oncology (Northwood, London, England)2020

A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer.

Damian A Laber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.